HR: hazard ratio; CI: confidence interval; IPI: International Prognostic Index; ALK negative ALCL: Anaplastic lymphoma kinase negative anaplastic large cell lymphoma; AITL: angioimmunoblastic T-cell lymphoma; PTCL NOS: peripheral T-cell lymphoma not otherwise specified; CT: computed tomography; PET: positron emission tomography; ASCT: autologous stem cell transplant.
Supplementary Table 6: Univariable analysis of factors associated with progression-free survival
PFS: progression-free survival; CI: confidence interval; HR: hazard ratio; PS: performance status; LDH: lactate dehydrogenase; IPI: International Prognostic Index; ALK negative ALCL: Anaplastic lymphoma kinase negative anaplastic large cell lymphoma; AITL: angioimmunoblastic T-cell lymphoma; PTCL NOS: peripheral T-cell lymphoma not otherwise specified; CHOP: cyclophosphamide, doxorubicin, vincristine, prednisolone; GEM-P: gemcitabine, cisplatin, methylprednisolone; CT: computed tomography; PET: positron emission tomography; ASCT: autologous stem cell transplant. HR: hazard ratio; CI: confidence interval; LDH: lactate dehydrogenase; IPI: International Prognostic Index; ALK negative ALCL: Anaplastic lymphoma kinase negative anaplastic large cell lymphoma; AITL: angioimmunoblastic T-cell lymphoma; PTCL NOS: peripheral T-cell lymphoma not otherwise specified; CT: computed tomography; PET: positron emission tomography; ASCT: autologous stem cell transplant.
